Cargando…

A Novel Bioimpedance-Based Detection of Miltefosine Susceptibility Among Clinical Leishmania donovani Isolates of the Indian Subcontinent Exhibiting Resistance to Multiple Drugs

The extent of susceptibility towards miltefosine (Mil), amphotericin B (AmpB), and paromomycin (Paro) was measured among 19 clinical isolates of Leishmania donovani (LD). Thirteen of these clinical isolates were reported to exhibit low susceptibility towards sodium stibogluconate (SSG-R), while six...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghosh, Souradeepa, Biswas, Souvik, Mukherjee, Sandip, Pal, Arijit, Saxena, Aaditya, Sundar, Shyam, Dujardin, Jean-Claude, Das, Soumen, Roy, Syamal, Mukhopadhyay, Rupkatha, Mukherjee, Budhaditya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667613/
https://www.ncbi.nlm.nih.gov/pubmed/34912730
http://dx.doi.org/10.3389/fcimb.2021.768830
_version_ 1784614415546449920
author Ghosh, Souradeepa
Biswas, Souvik
Mukherjee, Sandip
Pal, Arijit
Saxena, Aaditya
Sundar, Shyam
Dujardin, Jean-Claude
Das, Soumen
Roy, Syamal
Mukhopadhyay, Rupkatha
Mukherjee, Budhaditya
author_facet Ghosh, Souradeepa
Biswas, Souvik
Mukherjee, Sandip
Pal, Arijit
Saxena, Aaditya
Sundar, Shyam
Dujardin, Jean-Claude
Das, Soumen
Roy, Syamal
Mukhopadhyay, Rupkatha
Mukherjee, Budhaditya
author_sort Ghosh, Souradeepa
collection PubMed
description The extent of susceptibility towards miltefosine (Mil), amphotericin B (AmpB), and paromomycin (Paro) was measured among 19 clinical isolates of Leishmania donovani (LD). Thirteen of these clinical isolates were reported to exhibit low susceptibility towards sodium stibogluconate (SSG-R), while six of them were highly susceptible (SSG-S). The degree of clearance of amastigotes (EC50) for these predefined SSG-R- and SSG-S-infected macrophages was determined against Mil, AmpB, and Paro. Two out of the 13 SSG-R isolates (BHU575 and BHU814) showed low susceptibility towards all three drugs studied, while the rest of the 11 SSG-R isolates showed varying degrees of susceptibility either towards none or only towards individual drugs. Interestingly, all the SSG-S isolates showed high susceptibility towards Mil/AmpB/Paro. The total intracellular non-protein thiol content of the LD promastigotes, which have been previously reported to be positively co-related with EC50 towards SSG, was found to be independent from the degree of susceptibility towards Mil/AmpB/Paro. Impedance spectra analysis, which quantifies membrane resistance, revealed lower impedimetric values for all those isolates exhibiting low efficacy to Mil (Mil-R). Our analysis points out that while non-protein thiol content can be an attribute of SSG-R, lower impedimetric values can be linked with lower Mil susceptibility, although neither of these parameters seems to get influenced by the degree of susceptibility towards AmpB/Paro. Finally, a correlation analysis with established biological methods suggests that impedance spectral analysis can be used for the accurate determination of lower Mil susceptibility among LD isolates, which is further validated in the LD-infected in vivo hamster model.
format Online
Article
Text
id pubmed-8667613
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86676132021-12-14 A Novel Bioimpedance-Based Detection of Miltefosine Susceptibility Among Clinical Leishmania donovani Isolates of the Indian Subcontinent Exhibiting Resistance to Multiple Drugs Ghosh, Souradeepa Biswas, Souvik Mukherjee, Sandip Pal, Arijit Saxena, Aaditya Sundar, Shyam Dujardin, Jean-Claude Das, Soumen Roy, Syamal Mukhopadhyay, Rupkatha Mukherjee, Budhaditya Front Cell Infect Microbiol Cellular and Infection Microbiology The extent of susceptibility towards miltefosine (Mil), amphotericin B (AmpB), and paromomycin (Paro) was measured among 19 clinical isolates of Leishmania donovani (LD). Thirteen of these clinical isolates were reported to exhibit low susceptibility towards sodium stibogluconate (SSG-R), while six of them were highly susceptible (SSG-S). The degree of clearance of amastigotes (EC50) for these predefined SSG-R- and SSG-S-infected macrophages was determined against Mil, AmpB, and Paro. Two out of the 13 SSG-R isolates (BHU575 and BHU814) showed low susceptibility towards all three drugs studied, while the rest of the 11 SSG-R isolates showed varying degrees of susceptibility either towards none or only towards individual drugs. Interestingly, all the SSG-S isolates showed high susceptibility towards Mil/AmpB/Paro. The total intracellular non-protein thiol content of the LD promastigotes, which have been previously reported to be positively co-related with EC50 towards SSG, was found to be independent from the degree of susceptibility towards Mil/AmpB/Paro. Impedance spectra analysis, which quantifies membrane resistance, revealed lower impedimetric values for all those isolates exhibiting low efficacy to Mil (Mil-R). Our analysis points out that while non-protein thiol content can be an attribute of SSG-R, lower impedimetric values can be linked with lower Mil susceptibility, although neither of these parameters seems to get influenced by the degree of susceptibility towards AmpB/Paro. Finally, a correlation analysis with established biological methods suggests that impedance spectral analysis can be used for the accurate determination of lower Mil susceptibility among LD isolates, which is further validated in the LD-infected in vivo hamster model. Frontiers Media S.A. 2021-11-29 /pmc/articles/PMC8667613/ /pubmed/34912730 http://dx.doi.org/10.3389/fcimb.2021.768830 Text en Copyright © 2021 Ghosh, Biswas, Mukherjee, Pal, Saxena, Sundar, Dujardin, Das, Roy, Mukhopadhyay and Mukherjee https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Ghosh, Souradeepa
Biswas, Souvik
Mukherjee, Sandip
Pal, Arijit
Saxena, Aaditya
Sundar, Shyam
Dujardin, Jean-Claude
Das, Soumen
Roy, Syamal
Mukhopadhyay, Rupkatha
Mukherjee, Budhaditya
A Novel Bioimpedance-Based Detection of Miltefosine Susceptibility Among Clinical Leishmania donovani Isolates of the Indian Subcontinent Exhibiting Resistance to Multiple Drugs
title A Novel Bioimpedance-Based Detection of Miltefosine Susceptibility Among Clinical Leishmania donovani Isolates of the Indian Subcontinent Exhibiting Resistance to Multiple Drugs
title_full A Novel Bioimpedance-Based Detection of Miltefosine Susceptibility Among Clinical Leishmania donovani Isolates of the Indian Subcontinent Exhibiting Resistance to Multiple Drugs
title_fullStr A Novel Bioimpedance-Based Detection of Miltefosine Susceptibility Among Clinical Leishmania donovani Isolates of the Indian Subcontinent Exhibiting Resistance to Multiple Drugs
title_full_unstemmed A Novel Bioimpedance-Based Detection of Miltefosine Susceptibility Among Clinical Leishmania donovani Isolates of the Indian Subcontinent Exhibiting Resistance to Multiple Drugs
title_short A Novel Bioimpedance-Based Detection of Miltefosine Susceptibility Among Clinical Leishmania donovani Isolates of the Indian Subcontinent Exhibiting Resistance to Multiple Drugs
title_sort novel bioimpedance-based detection of miltefosine susceptibility among clinical leishmania donovani isolates of the indian subcontinent exhibiting resistance to multiple drugs
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667613/
https://www.ncbi.nlm.nih.gov/pubmed/34912730
http://dx.doi.org/10.3389/fcimb.2021.768830
work_keys_str_mv AT ghoshsouradeepa anovelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs
AT biswassouvik anovelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs
AT mukherjeesandip anovelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs
AT palarijit anovelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs
AT saxenaaaditya anovelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs
AT sundarshyam anovelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs
AT dujardinjeanclaude anovelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs
AT dassoumen anovelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs
AT roysyamal anovelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs
AT mukhopadhyayrupkatha anovelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs
AT mukherjeebudhaditya anovelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs
AT ghoshsouradeepa novelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs
AT biswassouvik novelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs
AT mukherjeesandip novelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs
AT palarijit novelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs
AT saxenaaaditya novelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs
AT sundarshyam novelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs
AT dujardinjeanclaude novelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs
AT dassoumen novelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs
AT roysyamal novelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs
AT mukhopadhyayrupkatha novelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs
AT mukherjeebudhaditya novelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs